Evaluation of outpatient health services in diabetes mellitus in a middle-income setting: a retrospective cohort study involving secondary care
Authors:
- Felipe Martins de OliveiraFOFelipe Martins de Oliveira
- Caio ChiaradiaCCCaio Chiaradia
- Silvana Marques ZaiaSZSilvana Marques Zaia
- Ana Carolina Xavier OrdonhaAOAna Carolina Xavier Ordonha
- Sônia Aparecida Dias GarciaSGSônia Aparecida Dias Garcia
- Ligia Dinara Donizeti ReisLRLigia Dinara Donizeti Reis
- Manoel Carlos Sampaio de Almeida RibeiroMRManoel Carlos Sampaio de Almeida Ribeiro
- João Eduardo Nunes SallesJSJoão Eduardo Nunes Salles
Open Access
- 23 June 2023
- journal article
- research article
- Published by Universidade Estadual de Maringa in Acta Scientiarum. Health Sciences
- Vol. 45, e60477
Abstract
In Brazil, it is necessary to assess the different levels of health care in diabetes mellitus (DM) in order to integrate them. In this retrospective cohort study, we analyzed 1,122 medical records of patients with DM from specialized services with interdisciplinary health teams (IHT) in the city of Ourinhos, São Paulo state, Brazil, to assess the impact of secondary care on glycemic control in patients with DM in those places and to compare baseline and follow-up DM care indicators concerning clinical evaluation and drug treatment regimens in the aforementioned health services. The study covered consultations carried out from September/2013 to September/2017. Data were collected from initial and final appointments in medical records and revealed an increase of 31.21% in insulin introduction and of 73.53% in regimens with three or more non-insulin antidiabetic (NIA) medications. Among the 570 patients with at least two glycated hemoglobin (A1C) measurements in the aforementioned review, 146 did not require any therapeutic adjustment between initial and final appointments, 123 required a subtle adjustment, 95, a moderate adjustment, and 206, an intense adjustment. There was a noticeably higher A1C reduction between initial and final appointments when patients who required an intense drug adjustment were compared to those who did not need any different NIA drug (p-value < 0.0001). In addition to optimizing drug treatment, essential exams in DM were performed with higher frequency, with an increase of 63% in ophthalmology evaluation performed during secondary care approach and 60.65% more individuals being screened for diabetic chronic kidney disease. IHT secondary care considered in this study, therefore, not only improved glycemic control of patients with DM, especially by optimization of NIA regimens and timely prescription of insulin, but also increased the screening for microvascular complications.Keywords
This publication has 16 references indexed in Scilit:
- IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045Diabetes Research and Clinical Practice, 2022
- Effect of a Pharmacist-Led Educational Intervention on Inappropriate Medication Prescriptions in Older AdultsJAMA, 2018
- Community Health Workers in Diabetes Prevention and Management in Developing CountriesAnnals of Global Health, 2017
- Diabetes Care in BrazilAnnals of Global Health, 2015
- Prevalence and Management of Diabetic Nephropathy in Western CountriesKidney Diseases, 2015
- Analysis of treatment of comorbidities and the profile of medical consultations for diabetes mellitusCiencia & Saude Coletiva, 2013
- Epidemiology, management, complications and costs associated with type 2 diabetes in Brazil: a comprehensive literature reviewGlobalization and Health, 2013
- Proportion of patients at HbA1c target <7% with eight classes of antidiabetic drugs in type 2 diabetes: systematic review of 218 randomized controlled trials with 78 945 patientsDiabetes, Obesity and Metabolism, 2011
- The Costs of Type 2 Diabetes Mellitus Outpatient Care in the Brazilian Public Health SystemValue in Health, 2011
- The effect of gliclazide and glibenclamide on preconditioning of the human myocardiumEuropean Journal of Pharmacology, 2005